Novo Nordisk's pre-market decline narrowed to 20%, with a previous drop of nearly 30% being the largest single day decline on record
六月清晨搅
发表于 2024-12-20 20:34:55
138
0
0
According to AI News, on December 20th, the pre-market decline of Novo Nordisk's US stock market narrowed to 20%, after a previous drop of nearly 30%, the largest single day decline on record, as the trial results of Novo Nordisk's weight loss drug CagriSema did not meet expectations.
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- Top 20 US Stock Exchange Transactions: TSMC Increases Over 9%, Market Value Exceeds $1 Trillion
- US stocks close down: Nasdaq falls more than 2%, large tech stocks generally decline
- After the US election, Tesla's stock price surged by nearly 15%. Elon Musk's net worth increased by $20.9 billion in a single day
- Tesla: Nevada Gigafactory produces over 1000 units of household energy storage system Powerwall in a single day
- Supermicro Computer's US stock rose 40% after closing, as it submitted a compliance plan to NASDAQ
- Pinduoduo's pre-market decline widens to 13%
- Top 20 US Stock Transactions: Adobe's Poor Performance, Stock Price Falls 13.7%
- Novo Nordisk's pre-market decline narrows to 20%
- Top 20 US Stock Transactions: Tesla Falls Nearly 5%, Domestic Car Companies Launch Price Reduction Promotion Strategy
- Faraday Future skyrockets by 78% after announcing $30 million in financing
